Raynaud phenomenon and digital ulcers in systemic sclerosis

被引:0
|
作者
Michael Hughes
Yannick Allanore
Lorinda Chung
John D. Pauling
Christopher P. Denton
Marco Matucci-Cerinic
机构
[1] Royal Hallamshire Hospital,Department of Rheumatology
[2] Sheffield Teaching Hospitals NHS Foundation Trust,Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health
[3] The University of Manchester,Department of Rheumatology
[4] Cochin Hospital,Division of Immunology and Rheumatology, Department of Medicine
[5] AP-HP,Department of Pharmacy and Pharmacology
[6] Paris Descartes University,Department of Rheumatology
[7] Stanford University School of Medicine and Palo Alto VA Health Care System,Division of Rheumatology
[8] University of Bath,undefined
[9] Royal National Hospital for Rheumatic Diseases (part of Royal United Hospitals Bath NHS Foundation Trust),undefined
[10] Royal Free Hospital,undefined
[11] University College London,undefined
[12] University of Florence,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Raynaud phenomenon is a symptom complex caused by impaired digital perfusion and can occur as a primary phenomenon or secondary to a wide range of underlying causes. Raynaud phenomenon occurs in virtually all patients with systemic sclerosis (SSc) and is often the earliest clinical manifestation to occur. Careful assessment is required in patients with Raynaud phenomenon to avoid missing secondary causes such as SSc. Digital ulcers are a painful and disabling visible manifestation of digital vascular injury in patients with SSc. Progress has been made in the classification and assessment of digital ulcers and in understanding ulcer pathogenesis, and there are a wide range of treatments available to both prevent and heal digital ulcers, some of which are also used in Raynaud phenomenon management. In this Review, the assessment of patients with Raynaud phenomenon is discussed, including ‘red flags’ that are suggestive of SSc. The pathogenesis, classification and assessment of SSc-associated digital ulcers are also covered, alongside an overview of management approaches for SSc-associated Raynaud phenomenon and digital ulcers. Finally, unmet needs are discussed and the concept of a unified vascular phenotype in which therapies that affect the vasculature to support disease modification strategies is introduced.
引用
收藏
页码:208 / 221
页数:13
相关论文
共 50 条
  • [1] Raynaud phenomenon and digital ulcers in systemic sclerosis
    Hughes, Michael
    Allanore, Yannick
    Chung, Lorinda
    Pauling, John D.
    Denton, Christopher P.
    Matucci-Cerinic, Marco
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (04) : 208 - 221
  • [2] Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis
    Botzoris, Vasileios
    Drosos, Alexandros A.
    [J]. JOINT BONE SPINE, 2011, 78 (04) : 341 - 346
  • [3] Author Correction: Raynaud phenomenon and digital ulcers in systemic sclerosis
    Michael Hughes
    Yannick Allanore
    Lorinda Chung
    John D. Pauling
    Christopher P. Denton
    Marco Matucci-Cerinic
    [J]. Nature Reviews Rheumatology, 2021, 17 : 246 - 246
  • [4] Botulinum toxin injection for refractory Raynaud phenomenon and digital ulcers in systemic sclerosis
    Shen, Yi-Hsuan
    Lee, Yung-Heng
    Leong, Pui-Ying
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (02) : 187 - 189
  • [5] Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis
    Galluccio, Felice
    Matucci-Cerinic, Marco
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (05) : 241 - 243
  • [6] Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
    Arefiev, Kait
    Fiorentino, David F.
    Chung, Lorinda
    [J]. INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2011, 2011
  • [7] Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
    Korsten, Peter
    Muller, Gerhard A.
    Rademacher, Jan-Gerd
    Zeisberg, Michael
    Tampe, Bjoern
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [8] Oral sildenafil for treatment of Raynaud phenomenon and digital ulcers secondary to scleroderma (systemic sclerosis).
    Gore, J
    Silver, R
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4085 - 4086
  • [9] Raynaud phenomenon and digital ulcers in systemic sclerosis (vol 16, pg 208, 2020)
    Hughes, Michael
    Allanore, Yannick
    Chung, Lorinda
    Pauling, John D.
    Denton, Christopher P.
    Matucci-Cerinic, Marco
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (04) : 246 - 246
  • [10] Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis
    Gore, J
    Silver, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1387 - 1387